Which pharmacodynamic property best distinguishes a full agonist from a partial agonist at the same receptor?

Explanation

## Distinguishing Full from Partial Agonists ### Intrinsic Activity (α) — The Key Discriminator **Key Point:** Intrinsic activity is the only pharmacodynamic property that definitively separates full agonists from partial agonists. | Property | Full Agonist | Partial Agonist | Antagonist | | --- | --- | --- | --- | | **Intrinsic Activity (α)** | α = 1.0 | 0 < α < 1.0 | α = 0 | | **Maximal Effect (E_max)** | Produces 100% of maximal response | Produces <100% of maximal response | No response | | **Affinity** | Variable; can be high or low | Variable; can be high or low | Variable; can be high or low | | **Clinical Outcome** | Full receptor occupancy → full effect | Partial receptor occupancy → submaximal effect | No effect despite binding | ### Why Intrinsic Activity is the Discriminator **High-Yield:** Intrinsic activity (α) quantifies the ability of a drug to produce a pharmacological effect once bound to a receptor: - **Full agonist:** α = 1.0 → produces maximal response at 100% receptor occupancy - **Partial agonist:** 0 < α < 1.0 → produces submaximal response even at 100% receptor occupancy **Clinical Pearl:** A partial agonist can act as a functional antagonist in the presence of a full agonist, because it occupies receptors without producing the maximal effect. ### Example: β-Blockers - **Propranolol** (full antagonist, α = 0) — no intrinsic activity - **Pindolol** (partial agonist, α ≈ 0.75) — retains some β-adrenergic activity; causes less bradycardia and less reduction in cardiac output - **Isoproterenol** (full agonist, α = 1.0) — maximal β-adrenergic effect ### Why Other Options Are Wrong **Affinity** (Option A) is the ability to bind to a receptor; both full and partial agonists can have high or low affinity. Affinity alone does not determine whether an agonist is full or partial. **Speed of onset** (Option C) is a pharmacokinetic property (absorption, distribution) unrelated to the intrinsic pharmacodynamic nature of the drug. **Plasma half-life** (Option D) is a pharmacokinetic parameter that affects duration of action, not the quality of receptor activation. **Mnemonic:** **IAMAE** — Intrinsic Activity Measures Agonist Efficacy. Remember: Affinity ≠ Activity.